[Radiofrequency-thermoablation in malignant liver disease].
The clinical application of radiofrequency tumor ablation in primary liver tumors and metastatic liver disease is rapidly growing because this technique has proven to be simple, safe, and effective in first clinical studies. Most of the patients with malignant liver disease are not candidates for surgical resection due to localisation or comorbidity, so radiofrequency therapy offers a good alternative for inoperable patients. With this method, high frequency alternating current is delivered to tissue via a needle electrode, the produced heat leads to coagulation necrosis. The largest focus of necrosis that can be induced with the currently available systems is approximately 4 - 5 cm with a single application. The radiofrequency needle is usually placed with US or CT guidance. For follow up examinations CT and MRI can be used, they proved to be equally accurate in the assessment of treatment response.
Pichler
L
L
Institut für Röntgendiagnostik im Donauspital/SMZ Ost + Wien, Ludwig, Germany. Ludwig.Pichler@smz.magwien.gv.at
Anzböck
W
W
Pärtan
G
G
Hruby
W
W
D017115:Catheter Ablation / Q000295:instrumentation / Q000379:methods; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000556:secondary / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D011677:Punctures; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography